Skip to content

HealthUnited States4 min read

Walgreens Nasal Spray Recall: Bacterial Contamination Risk

Over 41,000 bottles of Walgreens Saline Nasal Spray with Xylitol recalled nationwide due to Pseudomonas lactis contamination risk. Check your bottle's lot number.

Share

Topics

Walgreens nasal spray recall: Over 41,000 bottles pulled after Pseudomonas lactis contamination found

Walgreens has issued a nationwide Class II recall of more than 41,000 1.5-ounce bottles of its Saline Nasal Spray with Xylitol after laboratory tests confirmed Pseudomonas lactis contamination; consumers should check lot numbers and return affected bottles for refunds.

Main content

What happened

On Nov. 12, 2025, Walgreens and supplier Medical Products Laboratories, Inc. initiated a voluntary recall after laboratory testing detected Pseudomonas lactis in samples from two specific 1.5-ounce lots of the saline nasal spray. The supplier acted under FDA guidance to remove the product from shelves nationwide and notify consumers and public health authorities.

Why the FDA classified it Class II

The U.S. Food and Drug Administration categorized this as a Class II recall, meaning use of the product could cause temporary or medically reversible adverse health effects and the probability of serious long-term harm is remote. Local health officials and retailers were alerted to quickly remove remaining stock.

About the contaminant: Pseudomonas lactis

Testing identified the bacterium Pseudomonas lactis. Health officials note that while many healthy users face low risk, people with weakened immune systems or chronic respiratory conditions could be more likely to develop infection after exposure. Public advisories urge vigilance for infection signs and prompt medical care if symptoms appear.

What consumers should do now

  • Stop using any 1.5-ounce Walgreens Saline Nasal Spray with Xylitol until you check the lot number and expiration date printed on the bottle or box.
  • If your bottle is Lot #71409 (exp. Feb. 28, 2027) or Lot #71861 (exp. Aug. 31, 2027), return it to any Walgreens for a full refund. No receipt is required.
  • If you used an affected bottle and develop worsening nasal symptoms, fever, or other signs of infection, contact your healthcare provider. People with weakened immunity, lung disease, or chronic conditions should be especially careful.
  • Consult supplier and local public health notices for additional details and updates.

“Consumers must check lot numbers and stop using any affected product immediately; returns are being accepted for full refunds at Walgreens.”

How the recall was discovered and handled

Routine testing and sample analysis detected Pseudomonas lactis in product from the two lots. After confirmation, Medical Products Laboratories, guided by the FDA, issued a voluntary recall, informed Walgreens, and began notifying state and local public health departments. The supplier and retailer are removing product and offering refunds while documenting corrective actions.

Consumer safety context during cold and flu season

The recall coincides with increased use of over-the-counter nasal products during cold and flu season. Health officials warn that contaminated sprays could introduce bacteria into nasal passages, raising infection risk for susceptible individuals. The FDA’s Class II designation reflects that many users remain at low risk but certain groups face higher risk and should act promptly.

Investigation and next steps by supplier and agency oversight

Medical Products Laboratories reported the recall under FDA direction and is expected to investigate the contamination source and review manufacturing controls. The FDA will assess corrective actions and monitor recall effectiveness. Consumers should watch for updates if additional lots or issues are identified.

Reporting problems

Anyone who experienced adverse effects after using the product should report problems to the FDA’s MedWatch program and consult their doctor. Reporting helps regulators track illnesses tied to the recalled lots and decide whether further action is necessary.

Where to find more information

Implications for San Diego

Economic impact

The direct economic impact in San Diego is expected to be small: Walgreens will issue refunds and manage recall logistics. Local stores may see increased returns and staff time handling exchanges. Pharmacies and clinics should audit inventory and remove affected lots, which could temporarily raise operating costs.

Political consequences

Local health officials may issue advisories about safe nasal spray use, particularly for high-risk residents. City and county leaders could face questions on oversight of medical product distribution and preparedness for recalls. Lawmakers or consumer advocates might press for tougher manufacturing or inspection rules.

Social effects

San Diego’s population includes many older adults, active-duty military, and veterans—groups that may be vulnerable to infections from contaminated products. Families and caregivers should check medicine cabinets and return affected bottles. Community clinics and senior centers may need to share recall information and assist with returns.

Cultural relevance and practical tips

  • Check now: Inspect medicine cabinets for Walgreens Saline Nasal Spray with Xylitol in 1.5-ounce bottles and verify lot numbers Lot #71409 or Lot #71861.
  • Return: Bring any affected bottle to your nearest Walgreens for a refund; staff should accept returns without a receipt.
  • Seek care: If a high-risk person used an affected bottle and develops symptoms, contact a healthcare provider or local urgent care.
  • Share: Inform neighbors, caregivers, and community organizations—especially those serving older adults and veterans.

Public health notices and retail safety alerts are designed to limit harm quickly. This recall is a coordinated action by a supplier and regulators to remove a potentially risky product from store shelves and homes. Consumers nationwide, including San Diegans, should stop use, check lot numbers, and return affected bottles for refunds while monitoring for signs of infection.

Share

Topics

Kevin Morgan

Kevin Morgan is a veteran of the healthcare industry with decades of experience in science, research, and health innovation, including work as a government consultant. He covers health with an evidence-based, community-focused perspective while also following food and dining, politics, elections, and sports. An avid runner, Kevin values active, healthy living.

Write to Kevin